Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG

Notice to the media - Government of Canada to announce support to reduce health inequities for Canadians


ANTIGONISH, NS, Aug. 23, 2019 /CNW/ - The Honourable Ginette Petitpas Taylor, federal Minister of Health, will visit the National Collaborating Centre for Determinants of Health at St. Francis Xavier University and make an announcement.

The Minister will be available to media following the announcement.

Date
August 26, 2019

Time
11:00 AM (ADT)

Location
St. Francis Xavier University
Xaverian Gardens
4500 Alumni Crescent
Antigonish, Nova Scotia

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...



News published on and distributed by: